NCT06725095View on ClinicalTrials.gov

Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis

NAEnrolling by invitationINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

June 5, 2025

Conditions
MucositisPeri Implant Mucositis
Interventions
OTHER

Placebo gel

Patients were treated with non surgical peri-implant mucositis therapy with non-surgical sub-marginal peri-implant instrumentation plus the use of a placebo gel

OTHER

Enamel Matrix Proteins Derivative

Patients were treated with non surgical peri-implant mucositis therapy with non-surgical sub-marginal peri-implant instrumentation plus the use of non-surgical treatment plus Enamel Matrix Proteins Derivative

Trial Locations (1)

95124

Policlinico G. Rodolico, Catania

All Listed Sponsors
lead

University of Catania

OTHER